Lessee, Operating Lease, Liability, to be Paid, Year Two of SINOVAC BIOTECH LTD from 31 Dec 2018 to 31 Dec 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: SINOVAC BIOTECH LTD quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 31 Dec 2018 to 31 Dec 2023.
SINOVAC BIOTECH LTD Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Dec 2023 was $6,038,000, a 46% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

SINOVAC BIOTECH LTD Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2023	$6,038,000	-$5,050,000	-46%	31 Dec 2023	20-F	29 Apr 2024	2023	FY
Q4 2022	$11,088,000	-$8,219,000	-43%	31 Dec 2022	20-F	01 May 2023	2022	FY
Q4 2021	$19,307,000	+$8,686,000	+82%	31 Dec 2021	20-F	29 Apr 2022	2021	FY
Q4 2020	$10,621,000	+$9,815,000	+1218%	31 Dec 2020	20-F	22 Apr 2021	2020	FY
Q4 2019	$806,000	-$651,000	-45%	31 Dec 2019	20-F	30 Apr 2020	2019	FY
Q4 2018	$1,457,000			31 Dec 2018	20-F	29 Apr 2019	2018	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.